x

Search for a clinical trial

* (*) mandatory field

An open-label, multicenter, multinational study of the safety, efficacy and pharmacokinetics of ENB-0040 (asfotase alfa : human recombinant tissue nonspecific alkaline phosphatase fusion protein) in infants and children under 5 years of age with hypophosphatasia (HPP) (Phase II/III) - DE

  • Type of clinical trial : Drug clinical trial
  • Recruiting project : No
  • Status : Ongoing trial
  • Funding body(ies) :
  • Geographic coverage : Global
  • Sponsor : Alexion pharmaceuticals inc.
  • Website
  • Principal investigator of clinical trial

  • Pr Johannes G. LIESE
  • Kinderklinik und Poliklinik
  • Universitäts-Kinderklinik Würzburg
  • Josef-Schneider-Str. 2
  • 97080 WÜRZBURG
  • GERMANY
  • More information
  • Phone  : 49 (0)931 201 27831
  • Fax  : 49 (0)931 201 27833
  • Website
Last update: March 2017

Additional information

The documents contained in this web site are presented for information purposes only. The material is in no way intended to replace professional medical care by a qualified specialist and should not be used as a basis for diagnosis or treatment.